Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDNL.L Share News (DNL)

  • There is currently no data for DNL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Tullow Oil meets 2021 guidance; DP Eurasia sales rise

Wed, 26th Jan 2022 17:03

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

----------

Tullow Oil PLC - West Africa-focused oil and gas producer - For 2021, working interest oil production averages 59,200 barrels of oil per day, in line with guidance due to growth from the Jubilee field in Ghana and Simba field in Gabon. As a result, in addition to a realised oil price of USD63 per barrel, revenue is expected to be USD1.3 billion, down from USD1.40 billion in 2020. Looking ahead, 2022 production guidance is set between 55,000 to 61,000 barrels per day. However, this guidance will be adjusted following the sale of Occidental Petroleum's interest in Ghana to Kosmos Energy Ltd.

----------

DP Eurasia NV - master franchisee of the Domino's Pizza brand in Turkey, Russia, Azerbaijan and Georgia - For 2021, total systems sales increase 52% year-on-year to TRY2.38 billion, around USD175.4 million, from TRY1.60 billion, driven by strong demand in Turkey and an improved performance in Russia. On a like-for-like basis, system sales growth was 40.6% from 17.4%. Looking ahead, expects adjusted Ebitda for 2021 to be in line with expectations.

----------

Renew Holdings PLC - engineering services provider - For the first quarter ended December 31, performance is in line with management expectations, with order book standing at GBP742 million, up 9.6% from GBP677 million the same date a year before.

----------

Safestyle UK PLC - Bradford, England-based PVCu double-glazed windows provider - For the year ended January 2, underlying posttax profit is set to be ahead of market expectations, on top of revenue to rise 27% year-on-year to GBP143.3 million. Also reflects a 14% rise from the 2019 financial year. Looking ahead, expects operating conditions to improve in 2022.

----------

Real Estate Investors PLC - Midlands focused investment trust - Rent collections levels for 2021 reaches 97.8%, while occupancy at the year-end stood at 85.8%, down from 91.6% the year before.

----------

Ingenta PLC - Oxford, England-based provider of software and services to media - For 2021, expects revenue to remain flat at GBP10.1 million, but adjusted earnings before interest, tax, depreciation and amortisation at GBP1.5 million, up 25% from GBP1.2 million the year before. Will pay a final dividend of 2.0 pence per share for the year.

----------

ECSC Group PLC - Yorkshire, England and Brisbane, Australia-based cyber security services - For 2021, revenue rises 8% to GBP6.1 million from GBP5.7 million the year before, leading to expectations of positive adjusted Ebitda for the period.

----------

Zoo Digital Group PLC - Sheffield, England-based provider of cloud software and media services - For the year ending March 31, revenue is expected to be ahead of market expectations and come to at least USD57 million, a 44% rise from USD39.5 million the year before, driven by new territory launches and the return of new productions. Zoo has become the primary vendor for forthcoming European launch of a global streaming service, which is set to lead to significant orders.

----------

accesso Technology Group PLC - Berkshire, England-based provider of software for leisure, entertainment and cultural sectors - In spite of the effect of the new Omicron variant, for 2021 the company expects revenue be at least USD124 million, ahead of management expectations, and more than doubled from USD56.1 million in 2020. Also reflects a 5.8% rise from USD117.2 million in 2019.

----------

Oakley Capital Investments Ltd - investment trust - As at December 31, net asset value per share is 538 pence, up from 403p the same date a year prior. Over the course of 2021, the trust made GBP137 million in investments, and gained GBP121 million in the share of proceeds.

----------

Bloomsbury Publishing PLC - London-based publisher -For the year ending February 28, expects pretax profit and revenue to be ahead of current market expectations, which is for pretax profit of GBP20.1 million and revenue of GBP197.1 million. For the year prior, pretax profit was GBP17.3 million, and revenue GBP185.1 million.

----------

Diurnal Group PLC - Cardiff, Wales-based pharmaceutical company focused on hormonal diseases - Revenue for the six months ended December 31 rises 75% year-on-year to GBP2.2 million from GBP1.2 million, driven by growth in product sales of Alkindi and the initial launch of Efmody in Germany, UK and Austria. Looking ahead, Efmody sales are set to accelerate significantly in the first half of 2022, on expectations of receiving pricing and formulary approvals in its target European markets.

----------

Uniphar PLC - Dublin-based healthcare services firm - Performs in line with expectations for 2021, and expects to report at least an 8% rise in gross profit, driven by a strong performance from all businesses, especially Commercial & Clinical and Product Access.

----------

Gaming Realms PLC - London-based developer and licensor of mobile focused gaming content - For 2021, expects to report a 70% year-on-year increase in adjusted Ebitda to GBP5.6 million, and a 27% rise in revenue to GBP14.5 million, driven mainly by growth from the licensing business, which has launched in two new US iGaming markets of Michigan and Pennsylvania.

----------

By Dayo Laniyan; dayolaniyan@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
10 Jan 2019 11:33

Diurnal Shares Surge As Secures Second Patent For Chronocort In US

LONDON (Alliance News) - Diurnal Group PLC on Thursday said the US Patent & Trademark Office has granted the company a second US patent for Chronocort.Diurnal shares almost tripled on a

Read more
10 Jan 2019 11:26

Diurnal awarded US patent for Chronocort product

(Sharecast News) - Specialty pharmaceutical company Diurnal Group announced on Thursday that the US Patent and Trademark Office (USPTO) has granted a second US patent for its 'Chronocort' modified release hydrocortisone product.

Read more
17 Oct 2018 12:10

Diurnal halts US development of Chronocort after European trials come up short

(Sharecast News) - Speciality pharmaceutical company Diurnal has put all development activities for its modified release hydrocortisone product on hold after it failed to meet its primary endpoint in a recent phase-three European trial.

Read more
17 Oct 2018 10:41

Diurnal Puts All Chronocort US Development Activities On Hold

LONDON (Alliance News) - Diurnal Group PLC said Wednesday it decided to put all US development activities for its Chronocort product on hold, after it failed to meet its primary objective in its a

Read more
8 Oct 2018 17:07

LONDON MARKET CLOSE: Stocks End Lower On Chinese And Italian Woes

LONDON (Alliance News) - Stocks closed lower Monday on the actions of the Chinese and Italian governments, as the pound continued its fall on news from 10 Downing Street there remains "big in of

Read more
8 Oct 2018 15:15

Diurnal Group Child Adrenal Insufficiency Drug Approved In Scotland

LONDON (Alliance News) - Diurnal Group PLC said Monday the Scottish Medicines Consortium approved the routine use of Alkindi, a first-line treatment of young children with adrenal insufficiency to

Read more
8 Oct 2018 12:00

LONDON MARKET MIDDAY: China Prompts Sell-Off In Europe; Insurers Fall

LONDON (Alliance News) - Share prices in London had slipped firmly into the red by midday on Monday following a slump in Chinese equities overnight."Europe is following the Asian lead, with a 3%

Read more
8 Oct 2018 10:33

WINNERS & LOSERS SUMMARY: French Connection In Vogue On Possible Sale

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.----------FTSE 100 - up 1.0%. The asset manager confirmed it is in to

Read more
8 Oct 2018 09:29

Diurnal's endocrine drug does not meet trial objective

(Sharecast News) - Clinical trials of Diurnal Group's Chronocort drug failed to meet the primary objective of proving superior to conventional therapy in endocrine control over a 24-hour period.

Read more
8 Oct 2018 08:54

Shares In IP Group, Diurnal Suffer After Chronocort Trial Disappoints

LONDON (Alliance News) - Diurnal Group PLC said Monday its phase-three European trial of Chronocort did not meet its primary objective, causing shares in the pharmaceutical company to property IP

Read more
8 Oct 2018 07:48

LONDON MARKET PRE-OPEN: Lower Call; Schroders Confirms Lloyds Talks

LONDON (Alliance News) - Stocks in London on Monday are set to continue last week's slide, fuelled by concerns that strong US economic data will lead to a quickened pace of interest rate hikes.In

Read more
5 Oct 2018 09:20

Diurnal kicks off adrenal condition trial with first patients

(Sharecast News) - Specialist pharmaceutical company Diurnal said it had enrolled the first two patients in its US-based Chronocort phase III trial for adults with congenital adrenal hyperplasia (CAH).

Read more
5 Oct 2018 08:16

Diurnal Enrols First Patients In Phase Three US Chronocort Trial

LONDON (Alliance News) - Pharmaceutical company Diurnal Group PLC on Friday said the first two patients have been enrolled into its phase three US trial of Chronocort.Chronocort is a form a

Read more
20 Sep 2018 09:56

Diurnal Generates First Revenue But Loss Deepens As Costs Rise

LONDON (Alliance News) - Pharmaceutical firm Diurnal Group PLC said Thursday its annual loss deepened amid higher costs despite generating its first revenue from drug sales.For the year the

Read more
15 Aug 2018 12:39

German Body Says Diurnal Alkindi's Benefit Over Generic Not Proven

LONDON (Alliance News) - Diurnal Group PLC said Wednesday a German body published a study which says that the benefit of the company's product Alkindi over generic hydrocortisone has not been

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.